Senate odds for the CLARITY Act dropped to 48% after lawmakers clashed over developer protections. Over 60 crypto firms including Coinbase urged passage with BRCA intact.
Alpha Score of 24 reflects poor overall profile with poor momentum, poor value, weak quality, moderate sentiment.
The odds of the CLARITY Act passing the Senate tumbled to 48% on Wednesday from 55% a week earlier, according to Polymarket. The drop came after a coalition of more than 60 crypto firms urged lawmakers to move the bill forward with developer protections intact.
Coinbase, Kraken, Bitwise, a16z Crypto, Uniswap Labs, Solana Labs, Anchorage Digital and Galaxy each signed a letter to Senate Majority Leader John Thune. The letter backs the Blockchain Regulatory Certainty Act, or BRCA, a provision within CLARITY that carves out noncontrolling software developers from certain financial regulations. The signatories wrote that without that language, the broader market structure bill would not deliver the certainty needed for innovation.
Two issues have stalled the bill: developer liability protections and ethics rules for senators. A third, whether stablecoins can pay yield, remains unresolved. A Democratic Senate source described the ethics fight as "rocky," noting an "about-face" by Republican lawmakers and the White House on what was previously a negotiated deal.
Industry leaders contend the BRCA provision does not weaken the government's ability to pursue illicit finance. The coalition wrote: "Clear boundaries do not weaken enforcement; they strengthen it by distinguishing lawful activities from illicit or non-compliant conduct." The White House and law enforcement officials have held separate meetings to discuss how developer protections might affect digital-asset crime investigations. No official position has been announced.
For Coinbase, the only publicly traded signatory, the legislative outcome carries direct weight. A stalled or weakened CLARITY Act would leave the regulatory floor uncertain, forcing the exchange to operate under a patchwork of state laws and SEC enforcement. The company's Alpha Score sits at 24 out of 100, a Weak reading that reflects regulatory overhang among other factors.
The Senate is not expected to take up the bill before the July recess. A mark-up could come in September, provided the three sticking points are resolved. Until then, the 48% Polymarket odds are the closest proxy for the market's view.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.